In addition, another study described that SHMT2 and BCL2 cooperated to promote the occurrence of lymphoma through the silencing of epigenetic inhibitors, as the enhancement of SHMT2 metabolic enzyme activity was sufficient to convert normal B cells into B-cell lymphoma (37). This evidence concerns the gene BCL2 and lymphoma.